Tailored placement of a turn-forming PA tag into the structured domain of a protein to probe its conformational state

Journal of Cell Science

Volumn 129, Issue 7, 2016, Pages 1512-1522

  Fujii, Yuki ^a,b   Matsunaga, Yukiko ^a   Arimori, Takao ^a   Kitago, Yu ^a   Ogasawara, Satoshi ^b   Kaneko, Mika K ^b   Kato, Yukinari ^b   Takagi, Junichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epitope tag; Integrin; Reporter antibody; Site specific labeling; turn

Indexed keywords

ALPHA2BBETA3 INTEGRIN; ANTIBODY; INTEGRIN; NZ 1; PEPTIDE PA TAG; POLYPEPTIDE; SEMAPHORIN; UNCLASSIFIED DRUG; ALPHA2 INTEGRIN; BETA3 INTEGRIN; ITGA2B PROTEIN, HUMAN; ITGB3 PROTEIN, HUMAN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PDPN PROTEIN, HUMAN;

ARTICLE; CELL SURFACE; COMPLEX FORMATION; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; ANTIBODY COMBINING SITE; CELL LINE; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM;

ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; CELL LINE; HEK293 CELLS; HUMANS; INTEGRIN ALPHA2; INTEGRIN BETA3; MEMBRANE GLYCOPROTEINS; PROTEIN CONFORMATION; SEMAPHORINS;

EID: 84964048363     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.176685     Document Type: Article

References (48)

1. Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R.W. et al. (2010). PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213-221.
2. Bazzoni, G., Shih, D.-T., Buck, C. A. and Hemler, M. E. (1995). Monoclonal antibody 9eg7 defines a novel beta(1) integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. J. Biol. Chem. 270, 25570-25577.
3. Carman, C. V. and Springer, T. A. (2003). Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr. Opin. Cell Biol. 15, 547-556.
4. Chang, H. C., Bao, Z., Yao, Y., Tse, A. G., Goyarts, E. C., Madsen, M., Kawasaki, E., Brauer, P. P., Sacchettini, J. C., Nathenson, S. G. et al. (1994). A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments. Proc. Natl. Acad. Sci. USA 91, 11408-11412.
5. Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. and Richardson, D. C. (2010). MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12-21.
6. Coller, B. S. (1985). A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J. Clin. Invest. 76, 101-108.
7. Dennison, S. M., Anasti, K. M., Jaeger, F. H., Stewart, S. M., Pollara, J., Liu, P., Kunz, E. L., Zhang, R., Vandergrift, N., Permar, S. et al. (2014). Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide. J. Virol. 88, 9406-9417.
8. Dinculescu, A., McDowell, J. H., Amici, S. A., Dugger, D. R., Richards, N., Hargrave, P. A. and Smith, W. C. (2002). Insertional mutagenesis and immunochemical analysis of visual arrestin interaction with rhodopsin. J. Biol. Chem. 277, 11703-11708.
9. Dyson, H. J., Lerner, R. A. and Wright, P. E. (1988). The physical basis for induction of protein-reactive antipeptide antibodies. Annu. Rev. Biophys. Biophys. Chem. 17, 305-324.
10. Emsley, P., Lohkamp, B., Scott, W. G. and Cowtan, K. (2010). Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501.
11. Eswar, N., Eramian, D., Webb, B., Shen, M.-Y. and Sali, A. (2008). Protein structure modeling with MODELLER. Methods Mol. Biol. 426, 145-159.
12. Facey, S. J. and Kuhn, A. (2003). The sensor protein KdpD inserts into the Escherichia coli membrane independent of the Sec translocase and YidC. Eur. J. Biochem. 270, 1724-1734.
13. Fujii, Y., Kaneko, M., Neyazaki, M., Nogi, T., Kato, Y. and Takagi, J. (2014). PAtag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin. Protein Expres Purif. 95, 240-247.
14. Guruprasad, K. and Rajkumar, S. (2000). Beta-and gamma-turns in proteins revisited: a new set of amino acid turn-type dependent positional preferences and potentials. J. Biosci. 25, 143-156.
15. Humphries, M. J. (2004). Monoclonal antibodies as probes of integrin priming and activation. Biochem. Soc. Trans. 32, 407-411.
16. Humphries, M. J., Symonds, E. J. and Mould, A. P. (2003). Mapping functional residues onto integrin crystal structures. Curr. Opin. Struct. Biol. 13, 236-243.
17. Irannejad, R., Tomshine, J. C., Tomshine, J. R., Chevalier, M., Mahoney, J. P., Steyaert, J., Rasmussen, S. G. F., Sunahara, R. K., El-Samad, H., Huang, B. et al. (2013). Conformational biosensors reveal GPCR signalling from endosomes. Nature 495, 534-538.
18. Johnson, J. L., Entzminger, K. C., Hyun, J., Kalyoncu, S., Heaner, D. P., Jr, Morales, I. A., Sheppard, A., Gumbart, J. C., Maynard, J. A. and Lieberman, R. L. (2015). Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization. Acta Crystallogr. D Biol. Crystallogr. 71, 896-906.
19. Kabsch, W. (2010). Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125-132.
20. Kendall, R. T. and Senogles, S. E. (2006). Investigation of the alternatively spliced insert region of the D2L dopamine receptor by epitope substitution. Neurosci. Lett. 393, 155-159.
21. Koide, S. (2009). Engineering of recombinant crystallization chaperones. Curr. Opin. Struct. Biol. 19, 449-457.
22. Kouns, W. C., Steiner, B., Kunicki, T. J., Moog, S., Jutzi, J., Jennings, L. K., Cazenave, J. P. and Lanza, F. (1994). Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood 84, 1108-1115.
23. Krauss, N., Wessner, H., Welfle, K., Welfle, H., Scholz, C., Seifert, M., Zubow, K., Aÿ, J., Hahn, M., Scheerer, P. et al. (2008). The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops. Proteins 73, 552-565.
24. Luo, B.-H., Springer, T. A. and Takagi, J. (2004). A specific interface between integrin transmembrane helices and affinity for ligand. PLoS Biol. 2, e153.
25. McCoy, A. J., Grosse-Kunstleve, R.W., Adams, P. D., Winn, M. D., Storoni, L. C. and Read, R. J. (2007). Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674.
26. Mitchell, W. B., Li, J. H., Singh, F., Michelson, A. D., Bussel, J., Coller, B. S. and French, D. L. (2003). Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesis. Blood 101, 2268-2276.
27. Morlacchi, S., Sciandra, F., Bigotti, M. G., Bozzi, M., Hübner, W., Galtieri, A., Giardina, B. and Brancaccio, A. (2012). Insertion of a myc-tag within alphadystroglycan domains improves its biochemical and microscopic detection. BMC Biochem. 13, 14.
28. Mould, A. P., Barton, S. J., Askari, J. A., McEwan, P. A., Buckley, P. A., Craig, S. E. and Humphries, M. J. (2003). Conformational changes in the integrin beta A domain provide a mechanism for signal transduction via hybrid domain movement. J. Biol. Chem. 278, 17028-17035.
29. Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. and Vagin, A. A. (2011). REFMAC 5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355-367.
30. Nagae, M., Re, S., Mihara, E., Nogi, T., Sugita, Y. and Takagi, J. (2012). Crystal structure of alpha5beta1 integrin ectodomain: atomic details of the fibronectin receptor. J. Cell Biol. 197, 131-140.
31. Newman, P. J., Allen, R.W., Kahn, R. A. and Kunicki, T. J. (1985). Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood 65, 227-232.
32. O'shea, E. K., Lumb, K. J. and Kim, P. S. (1993). Peptide Velcro - design of a heterodimeric coiled coil. Curr. Biol. 3, 658-667.
33. Otwinowski, Z. and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326.
34. Peerschke, E. I. and Coller, B. S. (1984). A murine monoclonal antibody that blocks fibrinogen binding to normal platelets also inhibits fibrinogen interactions with chymotrypsin-treated platelets. Blood 64, 59-63.
35. Smith, W. C., Dinculescu, A., Peterson, J. J. and McDowell, J. H. (2004). The surface of visual arrestin that binds to rhodopsin. Mol. Vis. 10, 392-398.
36. Spangler, B. D. (1991). Binding to native proteins by antipeptide monoclonal antibodies. J. Immunol. 146, 1591-1595.
37. Springer, T. A. (1998). An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components. J. Mol. Biol. 283, 837-862.
38. Tainer, J. A., Getzoff, E. D., Alexander, H., Houghten, R. A., Olson, A. J., Lerner, R. A. and Hendrickson, W. A. (1984). The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein. Nature 312, 127-134.
39. Takagi, J. and Springer, T. A. (2002). Integrin activation and structural rearrangement. Immunol. Rev. 186, 141-163.
40. Takagi, J., Isobe, T., Takada, Y. and Saito, Y. (1997). Structural interlock between ligand-binding site and stalk-like region of beta1 integrin revealed by a monoclonal antibody recognizing conformation-dependent epitope. J. Biochem. 121, 914-921.
41. Takagi, J., Erickson, H. P. and Springer, T. A. (2001). C-terminal opening mimics "inside-out" activation of integrin a5b1. Nat. Struct. Biol. 8, 412-416.
42. Takagi, J., Petre, B. M., Walz, T. and Springer, T. A. (2002). Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110, 599-611.
43. Tomiyama, Y., Brojer, E., Ruggeri, Z. M., Shattil, S. J., Smiltneck, J., Gorski, J., Kumar, A., Kieber-Emmons, T. and Kunicki, T. J. (1992). A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3. J. Biol. Chem. 267, 18085-18092.
44. Walker, F., Orchard, S. G., Jorissen, R. N., Hall, N. E., Zhang, H.-H., Hoyne, P. A., Adams, T. E., Johns, T. G., Ward, C., Garrett, T. P. et al. (2004). CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor. J. Biol. Chem. 279, 22387-22398.
45. Wallace, A. C., Laskowski, R. A. and Thornton, J.M. (1995). LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127-134.
46. Wood, D. W. (2014). New trends and affinity tag designs for recombinant protein purification. Curr. Opin. Struct. Biol. 26, 54-61.
47. Xiao, T., Takagi, J., Coller, B. S., Wang, J.-H. and Springer, T. A. (2004). Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432, 59-67.
48. Zhu, J., Luo, B.-H., Xiao, T., Zhang, C., Nishida, N. and Springer, T. A. (2008). Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol. Cell 32, 849-861.